Pendal Group’s DexCom DXCM Stock Holding History

Pendal Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,068	Closed	-$213K	–	519
2020 Q3	$213K	Hold	2,068	–	–	﹤0.01%	419
2020 Q2	$210K	Buy	+2,068	New	+$185K	﹤0.01%	413
2019 Q2	–	Sell	-42,172	Closed	-$1.26M	–	444
2019 Q1	$1.26M	Buy	+42,172	New	+$1.48M	0.02%	268

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pendal Group's DXCM Position: Q4 2020 in Review

Pendal Group sold out of DexCom (DXCM) in Q4 2020, closing a stake of 2,068 shares — an estimated $213K sold.

Pendal Group first reported a position in DXCM in Q1 2019 and held it in 3 quarters. The position peaked at $1.26M in Q1 2019. 734 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Pendal Group reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
Pendal Group sold 2,068 DexCom shares in Q4 2020, an estimated $213K.
Pendal Group first reported a position in DexCom in Q1 2019 and held it in 3 quarters.
Pendal Group's DexCom position peaked at $1.26M in Q1 2019.
734 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Pendal Group's 13F filing for Q4 2020, filed 21 Jan 2021.